CAS: 56387-08-7; 2-Aminothiophene-3-Carboxylic Acid

该化合物是一种异环化合物,其特点是硫苯基骨柱上的氨基氨基和碳本体酸功能组.这一结构使它成为有机合成的多功能中间体,特别是用于制备药品,农用化学品和功能材料.它的被动反应场地允许选择性修改,从而能够构建复杂的分子框架.该化合物在标准条件下的稳定性和与共同合成方法的兼容性增强了其在研究和工业应用中的效用.此外,其硫苯核心有助于电子特性,使其在材料科学中具有价值.高纯度可以满足严格的研究和生产要求.

结构式图片

上下游产品

CAS号31891-06-2 2-氨基噻吩-3-羧酸乙酯 | CAS号31891-06-2 2-氨基噻吩-3-羧酸乙酯 | CAS号65076-02-0 2-((噻吩-3-基氨基)亚甲... | CAS号79242-76-5 2-(1H-吡咯-1-基)噻吩-3-羧酸

合成工艺路线路线简述

    2-氨基噻吩-3-甲酸乙酯置于sodium Hydroxide体系中,用 甲醇 作为反应溶剂,化学反应生成 2-氨基噻吩-3-甲酸
    参考文献:Design,Synthesis And Structure-activity-Relationship Of 1,5-Tetrahydronaphthyridines As Cetp Inhibitors
    标题:Design,Synthesis And Structure-activity-Relationship Of 1,5-Tetrahydronaphthyridines As Cetp Inhibitors
    摘要:This Letter Describes The Discovery And Sar Optimization Of 1,5-Tetrahydronaphthyridines,A New Class Of Potent Cetp Inhibitors. The Effort Led To The Identification Of 21B And 21D With In Vitro Human Plasma Cetp Inhibitory Activity In The Nanomolar Range (Ic50 = 23 And 22 Nm,Respectively). Both 21B And 21D Exhibited Robust Hdl-C Increase In Hcetp/hapoa1 Dual Heterozygous Mice Model. (C) 2012 Elsevier Ltd. All Rights Reserved.
    DOI:10.1016/j.Bmcl.2012.03.075

    海关参考信息

    专利信息


    专利号:US-7576211-B2
    优先权日:2004-09-30
    标题 :Synthesis of thienopyridinone compounds and related intermediates
    发明人:DHANOA DALE S; BECKER OREN; NOIMAN SILVIA; CHEN DONGLI; MARANTZ YAEL; SHACHAM SHARON; HEIFETZ ALEXANDER; INBAL BOAZ; BAR-HAIM SHAY; MOHANTY PRADYUMNA; LOBERA MERCEDES; WU LAURENCE
    权利人:EPIX DELAWARE INC
    摘要:The invention relates to 5-HT receptor agonists and partial agonists. Novel thienopyridinone compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include Alzheimer's disease, cognition disorders, irritable bowel syndrome, nausea, emesis, vomiting, prokinesia, gastroesophageal reflux disease, nonulcer dyspepsia, depression, anxiety, urinary incontinence, migraine, arrhythmia, atrial fibrillation, ischemic stroke, gastritis, gastric emptying disorders, feeding disorders, gastrointestinal disorders, constipation, erectile dysfunction, and respiratory depression. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.

    专利号:US-4701528-A
    优先权日:1985-12-23
    标 题 :Intermediates useful in the preparation of 3,4-dihydro-4-oxothieno[2,3-d]pyrimidine-2-carboxylates and process for preparing same
    发明人:THOMPSON MICHAEL D; MADDING GARY D
    权利人:BRISTOL MYERS CO
    摘要:There are disclosed compounds of Formulas I and II: ##STR1## wherein R 1 and R 2 may be hydrogen, lower alkyl having from 1 to 8 carbon atoms, lower alkenyl having from 3 to 6 carbon atoms, lower alkoxy having from 1 to 6 carbon atoms, hydroxy, nitro, amino, halo including chlorine, bromine, iodine, and fluorine, phenyl, alkanoyl having from 2 to 6 carbon atoms or they are bonded to one another to form a cycloalkene ring fused to the thiophene ring and having a total of from 5 to 7 annular ring carbon atoms, and R 3 is an aliphatic or an aromatic group such as lower alkyl, e.g., methyl or ethyl. Such compounds are useful as intermediates in the production of tiprinast and related compounds. n There is also disclosed a process for the regioselective synthesis of a compound of Formula I wherein R 1 is CH 3 and R 2 is (CH 3 ) 2 CHCH 2 which comprises reacting a mixture of compounds of the following formulas: ##STR2## and ##STR3## with trichloroacetonitrile under acidic conditions.

    专利号:US-2006084805-A1
    优先权日:2004-09-30
    标题:Synthesis of thienopyridinone compounds and related intermediates

    专利号:US-7982040-B2
    优先权日:2004-05-17
    标题 :Thienopyridinone compounds and methods of treatment
    发明人:DHANOA DALE S; BECKER OREN; NOIMAN SILVIA; MOHANTY PRADYUMNA; CHEN DONGLI; LOBERA MERCEDES; WU LAURENCE; MARANTZ YAEL; INBAL BOAZ; HEIFETZ ALEXANDER; BAR-HAIM SHAY; SHACHAM SHARON
    权利人:NANOTHERAPEUTICS INC
    摘要:The invention relates to 5-HT receptor agonists and partial agonists. Novel thienopyridinone compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include Alzheimer's disease, cognition disorders, irritable bowel syndrome, nausea, emesis, vomiting, prokinesia, gastroesophageal reflux disease, nonulcer dyspepsia, depression, anxiety, urinary incontinence, migraine, arrhythmia, atrial fibrillation, ischemic stroke, gastritis, gastric emptying disorders, feeding disorders, gastrointestinal disorders, constipation, erectile dysfunction, and respiratory depression. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.

    专利号:WO-2005073265-A1
    优先权日:2004-02-04
    标题 :Conjugated thiophenes having conducting properties and synthesis of same

    专利号:NO-327896-B1
    优先权日:1999-01-19
    标 题 :Tricyclic benzodiazepines, pharmaceutical composition, use of the compounds and intermediates useful in the synthesis of the compounds
    上海郎威化学科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.langwaychem.com
    企业联系电话:021-67639201👤
    📞上海郎威化学科技有限公司 ⚠️参考联系方式
    联系人:黄先生
    电话:021-67639201
    手机:13601755340
    传真:021-57636317
    邮箱:customer@langwaychem.com
    通信地址: 上海松江高科技园区健鹏路118号
    邮编: 201615
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海松江高科技园区健鹏路118号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s11172-024-4477-2
    摘要:Gorbunova IA, Parkhoma KY, Kozlov DA, Nikonov IP, Denislamova ES, Makhmudov RR, Shipilovskikh DA. Synthesis of the substituted derivatives of sodium 5-aryl-5-oxo-3-[(thiophen-2-yl)amino]penta-1,3-dien-2-olates and evaluation of their antinociceptive activity in vivo. Russ Chem Bull. 2024 Dec;73(12):3669–76. doi: 10.1007/s11172-024-4477-2.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知